RepliCel Life Sciences Inc. REPCF Company Overview Stock

New Post Public Reply Private Reply Replies (0) Message Board

Sep 18, 2013 at 4:26 PM

RepliCel Life Sciences Inc. REPCF Company Overview

Stock Message Board http://investorshangout.com/search?q=REPCF&am...mp;yt1=Go!

RepliCel Life Sciences Inc. REPCF Current Price and Quotes
Last Price 0.46
Previous Close 0.45 Open 0.46
Daily Range 0.46 - 0.46 52wk Range 0.91 - 0.30
Volume 8,542 Dividend N/A
Average Vol (3m) 4,706 Yield N/A
RepliCel Life Sciences Inc. REPCF
Company Information

Suite 2020 - 401 West Georgia Street
Vancouver, BC V6B 5A1
Canada

Website: http://www.replicel.com
Phone: 604-248-8730
Email: info@replicel.com

RepliCel Life Sciences Inc. REPCF
RepliCel Life Sciences Inc. has developed RepliCel, a natural hair cell replication technology that has the potential to become the world's first, minimally invasive solution for androgenetic alopecia (pattern baldness) and general hair loss in men and women. RepliCel is based on autologous cell implantation technology that replicates a patient's hair cells from their own healthy hair follicles and, when reintroduced into areas of hair loss, the Company hopes to initiate natural hair regenerati...

RepliCel Life Sciences Inc. REPCF
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Dec 31, 2012 20-F
CIK 0001205059
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 1040 - Gold and Silver Ores
Business Status Development Stage Company a/o Aug 16, 2011
Incorporated In: Canada
Year of Inc. 1967
Employees 9 a/o Aug 16, 2011
Company Officers/Contacts

David Hall CEO, President
Tom Kordyback CFO
Gemma Bayley VP, Fin.
Tammey George Director, Comm., IR
Company Directors

Not Available
Company Notes

Formerly=Newcastle Resources Ltd. until 7-2011
Formerly=Pan American Gold Corp. until 11-2008
Formerly=Tri-Lateral Venture Corp. until 6-04
Service Providers

Auditor/Accountant
BDO Canada LLP
600 Cathedral Place - 925 West Georgia Street
Vancouver, V6C 3L2
Canada

Legal Counsel
Clark Wilson LLP
Suite 900
Vancouver, BC, V6C 3H1
Canada

Investor Relations Firm
Not Available

RepliCel Life Sciences Inc. REPCF
REPCF Security Details

Share Structure

Market Value1 $20,261,274 a/o Sep 17, 2013
Shares Outstanding 45,025,054 a/o Dec 31, 2012
Float Not Available
Authorized Shares Not Available
Par Value No Par Value
Shareholders

Shareholders of Record 2,706 a/o Aug 16, 2011
Security Notes

Capital Change=shs increased by 7 for 1 split Ex-date=06/02/2004.
Capital Change=shs decreased by 1 for 30 split. Pay date=11/28/2008.
Non US Stock Exchange Listing

P6P1 - Frankfurt Stock Exchange
Short Selling Data

Short Interest 3,610 (0%)
Aug 30, 2013
Significant Failures to Deliver No
Transfer Agent(s)

Canadian Stock Transfer Company, Inc

RepliCel Life Sciences Inc. REPCF Recent News

Sept 6, 2013 RepliCel Announces Stock Option Grant
Sept 4, 2013 RepliCel Retains Westwicke Partners as Investor Relations Counsel
Jul 20, 2013 RepliCel Announces Closing of Private Placement
Jul 11, 2013 RepliCel and Shiseido Complete Collaboration and Technology Transfer Agreement on Technology for Treating Pattern Baldness

RepliCel Life Sciences Inc. REPCF Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Jan 01, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development 1,070 1,001 554 -
Sales, General and Admin. 3,322 2,541 1,880 481
Non-Recurring Items 96 117 118 49
Other 6 7 7 2
Operating Income (4,493) (3,666) (2,559) (532)
Income From Continuing Operations

Add'l Income/Expense Items 1,116 20 - -
Earnings Before Interest and Tax (3,378) (3,647) (2,559) (532)
Interest Expense - - - -
Earnings Before Tax (3,378) (3,647) (2,559) (532)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,378) (3,647) (2,559) (532)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,378) (3,647) (2,559) (532)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,378) (3,647) (2,559) (532)

REPCF RepliCel Life Sciences Inc. Research DD Guide

REPCF RepliCel Life Sciences Inc. Stock Message Board http://investorshangout.com/search?q=REPCF&am...mp;yt0=Go!
REPCF RepliCel Life Sciences Inc. Stock Quote http://www.otcmarkets.com/stock/REPCF/quote
REPCF RepliCel Life Sciences Inc. Stock Chart http://www.otcmarkets.com/stock/REPCF/chart
REPCF RepliCel Life Sciences Inc. Company Info http://www.otcmarkets.com/stock/REPCF/company-info
REPCF RepliCel Life Sciences Inc. Recent News http://www.otcmarkets.com/stock/REPCF/news
REPCF RepliCel Life Sciences Inc. Financials http://www.otcmarkets.com/stock/REPCF/financials
REPCF RepliCel Life Sciences Inc. Filings and Disclosure http://www.otcmarkets.com/stock/REPCF/filings
REPCF RepliCel Life Sciences Inc. Short Sales http://www.otcmarkets.com/stock/REPCF/short-sales
REPCF RepliCel Life Sciences Inc. Insider Disclosure http://www.otcmarkets.com/stock/REPCF/insider-transactions
REPCF RepliCel Life Sciences Inc. Research Reports http://www.otcmarkets.com/stock/REPCF/research
REPCF RepliCel Life Sciences Inc. Summary http://finance.yahoo.com/q?s=REPCF
REPCF RepliCel Life Sciences Inc. Historical Prices http://finance.yahoo.com/q/hp?s=REPCF+Historical+Prices
REPCF RepliCel Life Sciences Inc. Interactive Chart http://finance.yahoo.com/echarts?s=REPCF
REPCF RepliCel Life Sciences Inc. Basic Chart http://finance.yahoo.com/q/bc?s=REPCF+Basic+Chart
REPCF RepliCel Life Sciences Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=REPCF+Basic+Tech.+Analysis
REPCF RepliCel Life Sciences Inc. Headlines http://finance.yahoo.com/q/h?s=REPCF+Headlines
REPCF RepliCel Life Sciences Inc. Press Releases http://finance.yahoo.com/q/p?s=REPCF+Press+Releases
REPCF RepliCel Life Sciences Inc. Company Profile http://finance.yahoo.com/q/pr?s=REPCF+Profile
REPCF RepliCel Life Sciences Inc. Key Statistics http://finance.yahoo.com/q/ks?s=REPCF+Key+Statistics
REPCF RepliCel Life Sciences Inc. Industry http://finance.yahoo.com/q/in?s=REPCF+Industry
REPCF RepliCel Life Sciences Inc. Major Holders http://finance.yahoo.com/q/mh?s=REPCF+Major+Holders
REPCF RepliCel Life Sciences Inc. Insider Transactions http://finance.yahoo.com/q/it?s=REPCF+Insider+Transactions
REPCF RepliCel Life Sciences Inc. Insider Roster http://finance.yahoo.com/q/ir?s=REPCF+Insider+Roster
REPCF RepliCel Life Sciences Inc. Income Statement http://finance.yahoo.com/q/is?s=REPCF
REPCF RepliCel Life Sciences Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=REPCF
REPCF RepliCel Life Sciences Inc. Cash Flow http://finance.yahoo.com/q/cf?s=REPCF+Cash+Flow&annual
REPCF RepliCel Life Sciences Inc. Nasdaq http://www.nasdaq.com/symbol/REPCF
REPCF RepliCel Life Sciences Inc. Market Watch http://www.marketwatch.com/investing/stock/REPCF
REPCF RepliCel Life Sciences Inc. Bloomberg http://www.bloomberg.com/quote/REPCF:US
REPCF RepliCel Life Sciences Inc. Morningstar http://quotes.morningstar.com/stock/s?t=REPCF
REPCF RepliCel Life Sciences Inc. Bussinessweek http://investing.businessweek.com/research/st...cker=REPCF
REPCF RepliCel Life Sciences Inc. Barchart http://www.barchart.com/quotes/stocks/REPCF
REPCF RepliCel Life Sciences Inc. OTC Short Report http://otcshortreport.com/index.php?index=REPCF
REPCF RepliCel Life Sciences Inc. Investopedia http://www.investopedia.com/markets/stocks/REPCF/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quantum Space Joins $185M NASA Lunar Transport Deal

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Allergan Aesthetics Study Shows Rising Patient Satisfaction

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

TCL's Display Future: AI Meets Screens at DTC 2026

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Novo's Semaglutide Shows Promise in MASH Study

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Webull Faces Class Action Suit: Key Deadlines Loom

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....